HSDT
Helius Medical Technologies Inc Class A
2.60$
-8.4%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +232.2% | 0.0% | +68.5% | +308.7% | -62.8% | -36.7% | +115.4% | +22.6% | -55.5% | -54.0% | +8,480.7% | |
| – | +232.2% | 0.0% | +63.8% | +307.4% | -73.1% | -35.3% | +168.8% | +32.6% | -56.3% | -53.1% | +809.9% | |
| – | +531.2% | +0.0% | +110.4% | +360.0% | -78.7% | -39.0% | +230.4% | +32.2% | -64.4% | -79.0% | +569.3% | |
| – | +231.8% | +0.0% | +110.4% | +360.0% | -78.7% | -39.0% | +230.4% | +32.2% | -64.4% | -79.0% | +569.3% | |
| – | +4,418.4% | +0.0% | +76.4% | -60.9% | +108.7% | -59.9% | +9.1% | +36.7% | +85.7% | -0.3% | – | |
| – | – | – | – | – | +52.6% | -34.9% | +22.4% | +23.7% | -22.4% | +138.7% | +2.7% | |
| – | – | – | – | +220.2% | +128.2% | -61.6% | -15.2% | +9.2% | – | – | – | |
| – | – | – | – | – | – | -38.9% | +0.5% | -100.0% | – | – | – | |
| – | – | – | – | – | – | -9.5% | -36.8% | -58.0% | -82.9% | – | – | |
| – | +46.0% | +0.0% | +252.5% | +25.7% | -74.9% | -40.7% | +6.4% | +221.0% | -41.5% | -53.5% | +21.5% | |
| – | +94.6% | +0.0% | +513.4% | +25.7% | -78.8% | -36.2% | +9.4% | -25.1% | -5.5% | +15.1% | +39.4% | |
| – | – | – | -77.4% | +1,264.6% | -98.8% | -65.7% | -94.9% | +1,700.0% | -16.7% | -73.3% | – | |
| – | +82.1% | -0.9% | +61.0% | -31.2% | -29.9% | -55.4% | +43.1% | -41.3% | -15.3% | +64.4% | +116.5% | |
| – | +9.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -40.8% | -33.7% | +190.8% | -27.6% | -71.2% | -54.9% | +28,314.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +42.0% | +22.3% | +15.7% | +59.1% | +105.1% | +449.4% | +125.2% | +345.8% | +610,129.6% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.